Dermazol cream 20mg/g of a tube of 15 g

Cream "Dermazol ^® " is intended for topical administration at treatment of the infections of skin caused by dermatophytes: epidermophitias of a body, the hands, a foot, an inguinal epidermophitia caused by Trichophyton rubrum, Trichophyton mentagrophytes, Microsporum canis and Epidermophyton floccosum - and also for treatment of candidiasis of skin and a chromophytosis. Also it is necessary to appoint medicine for treatment of seborrheal dermatitis - the condition of skin connected with presence of Malassezia furfur.

Structure

Active ingredient - ketokonazol (1 g of cream supports a ketokonazol of 20 mg).

Excipients: propylene glycol, alcohol tsetosterilovy, tsetomakrogol 1000, paraffin white soft, oil a mineral lung, dinatrium edetat, sodium sulfite waterless (E 221), polysorbate 80, water purified.

Contraindication

Cream "Dermazol ^® " is contraindicated to persons with hypersensitivity to a ketokonazol or to any of medicine ingredients.

Cream "Dermazol ^® " to apply

outwardly. To apply cream to the affected skin and surrounding sites. It is necessary to follow the general rules of hygiene to control sources of an infection and reinfection.

For all patients duration of treatment has to be based on the individual response to therapy.

Recommended dosage:

• skin candidiasis (barmy infections) - 1 time a day 2-3 weeks;
• a chromophytosis - 1 time a day 2-3 weeks;
• an inguinal epidermophitia - 1 time a day 2-4 weeks;
• a body epidermophitia - 1 time a day 3-4 weeks;
• an epidermophitia of hands - 1 times a day 4-6 weeks;
• an epidermophitia a foot - 1 time a day 4-6 weeks;
• seborrheal dermatitis (main therapy) - 1-2 times a day 2-4 weeks;
• seborrheal dermatitis (maintenance therapy) - 1 or 2 times a week.

Treatment has to continue during sufficient time, at least within several more days after disappearance of all symptoms. If symptoms of a disease do not disappear after 4 weeks of treatment, it is necessary to revise the diagnosis.

Feature of application

Pregnant women

Are absent adequate and well controlled researches of use of cream with ketokonazoly pregnant and nursing. After topical administration ketokonazol in blood plasma of non-pregnant women is not defined. The risks connected with use of medicine during pregnancy and feeding by a breast are unknown.

Children

Experience of use of cream "Dermazol ^® " at children is absent.

Drivers

Drug does not affect ability to steer motor transport or to work with other mechanisms.

Overdose

Topical administration of cream in excess quantity can cause an erythema, hypostasis, feeling of a burn of skin which quickly pass after the therapy termination.

At accidental intake should host the supporting and symptomatic therapeutic actions.

Side effects

from the immune system: reactions of hypersensitivity.

from skin and hypodermic cellulose: burning sensation, rashes, bullous rashes, contact dermatitis, peeling or stickiness of skin, small tortoiseshell.

to Store

in original packing at a temperature not above 25 °C, out of children's reach.

Expiration date - 4 years.